Clementia Pharmaceuticals (Clementia Pharmaceuticals) Receivables Turnover : 0.00 (As of Dec. 2018)

View and export this data going back to 2017. Start your Free Trial

What is Clementia Pharmaceuticals Receivables Turnover?

The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Clementia Pharmaceuticals's Revenue for the three months ended in Dec. 2018 was $0.00 Mil. Clementia Pharmaceuticals's average Accounts Receivable for the three months ended in Dec. 2018 was $0.00 Mil.

Clementia Pharmaceuticals Receivables Turnover Historical Data

The historical data trend for Clementia Pharmaceuticals's Receivables Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Clementia Pharmaceuticals Receivables Turnover Chart

Clementia Pharmaceuticals Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Receivables Turnover

Clementia Pharmaceuticals Quarterly Data
	Dec14	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18
Receivables Turnover	Get a 7-Day Free Trial									-	-	-	-	-

Competitive Comparison of Clementia Pharmaceuticals's Receivables Turnover

For the Biotechnology subindustry, Clementia Pharmaceuticals's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Clementia Pharmaceuticals's Receivables Turnover Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Clementia Pharmaceuticals's Receivables Turnover distribution charts can be found below:

* The bar in red indicates where Clementia Pharmaceuticals's Receivables Turnover falls into.

Clementia Pharmaceuticals Receivables Turnover Calculation

Receivables Turnover measures the number of times a company collects its average accounts receivable balance.

Clementia Pharmaceuticals's Receivables Turnover for the fiscal year that ended in Dec. 2018 is calculated as

	Receivables Turnover (A: Dec. 2018 )
=	Revenue	/	Average Total Inventories
=	Revenue (A: Dec. 2018 )	/ (	(Accounts Receivable (A: Dec. 2017 )	+	Accounts Receivable (A: Dec. 2018 ))	/	count )
=	0	/ (	(0	+	0)	/	1 )
=	0	/	0
=	N/A

Clementia Pharmaceuticals's Receivables Turnover for the quarter that ended in Dec. 2018 is calculated as

	Receivables Turnover (Q: Dec. 2018 )
=	Revenue	/	Average Total Inventories
=	Revenue (Q: Dec. 2018 )	/ (	(Accounts Receivable (Q: Sep. 2018 )	+	Accounts Receivable (Q: Dec. 2018 ))	/	count )
=	0	/ (	(0	+	0)	/	1 )
=	0	/	0
=	N/A

Clementia Pharmaceuticals (NAS:CMTA) Receivables Turnover Explanation

An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.

Clementia Pharmaceuticals Receivables Turnover Related Terms

Thank you for viewing the detailed overview of Clementia Pharmaceuticals's Receivables Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.

Clementia Pharmaceuticals (Clementia Pharmaceuticals) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Clementia Pharmaceuticals Inc (NAS:CMTA) » Definitions » Receivables Turnover

Comparable Companies

Traded in Other Exchanges

N/A

Address

4150 St Catherine Street West, Suite 550, Montreal, QC, CAN, H3Z 2Y5

Website

http://www.clementiapharma.com

Clementia Pharmaceuticals Inc is a clinical stage biopharmaceutical company. It is developing disease-modifying treatments for patients suffering from debilitating bone and other diseases with high unmet medical need. The company's lead product candidate, palovarotene, is an oral small molecule that has shown potent activity in preventing abnormal new bone formation as well as fibrosis in a variety of tissues. Clementia is developing palovarotene for the treatment of Fibrodysplasia Ossificans Progressiva (FOP) and Multiple Osteochondroma (MO). It believes that if approved in FOP or MO, palovarotene could become the standard of care in either or both of these indications.